Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Ehab Atallah, MD
Videos
Management of CML: New Agents and Monitoring for MRD
10/19/2022
Ehab Atallah, MD, provides an update on the management of patients with CML, highlighting new available agents and the role of monitoring for MRD.
Ehab Atallah, MD, provides an update on the management of patients with CML, highlighting new available agents and the role of monitoring for MRD.
Ehab Atallah, MD, provides an...
10/19/2022
Oncology
Dr Paul
Videos
Dr Paul Discusses Magrolimab Combinations in Patients With R/R MM
11/29/2021
Barry Paul, MD, discusses a phase 2 multi-arm study of magrolimab combinations in patients with R/R MM. These data were presented at the 2021 LL&M Congress.
Barry Paul, MD, discusses a phase 2 multi-arm study of magrolimab combinations in patients with R/R MM. These data were presented at the 2021 LL&M Congress.
Barry Paul, MD, discusses a...
11/29/2021
Oncology
Dr Lee
Videos
Dr Lee Highlights the Treatment Landscape for Patients With MDS, AML
11/29/2021
Sangmin Lee, MD, highlights the current treatment landscape for patients with MDS, including novel therapies that are in development in combination with hypomethylating agents.
Sangmin Lee, MD, highlights the current treatment landscape for patients with MDS, including novel therapies that are in development in combination with hypomethylating agents.
Sangmin Lee, MD, highlights the...
11/29/2021
Oncology
Dr Wang
Videos
Live CLL Cells Inside Bone Marrow Fibroblasts May Have Implication in Drug Resistance
11/29/2021
Lynn Wang, MD, PhD, FCAP, discusses live CLL cells inside the bone marrow fibroblasts and their implication in drug resistance. These data were presented at the 2021 LL&M Congress.
Lynn Wang, MD, PhD, FCAP, discusses live CLL cells inside the bone marrow fibroblasts and their implication in drug resistance. These data were presented at the 2021 LL&M Congress.
Lynn Wang, MD, PhD, FCAP,...
11/29/2021
Oncology
Dr Cheson
Videos
Dr Cheson Discusses Anti-CD20 Monoclonal Antibodies in Patients With CLL
11/23/2021
Bruce Cheson, MD, FACP, FAAAS, FASCO, discusses anti-CD20 monoclonal antibodies for the management of patients with CLL; these data were presented at the virtual LL&M Congress.
Bruce Cheson, MD, FACP, FAAAS, FASCO, discusses anti-CD20 monoclonal antibodies for the management of patients with CLL; these data were presented at the virtual LL&M Congress.
Bruce Cheson, MD, FACP, FAAAS,...
11/23/2021
Oncology
Dr Leonard
Videos
John Leonard, MD, Discusses the Lymphoma Treatment Landscape
11/04/2021
Dr Leonard discusses the complex landscape and management of patients with lymphoma, including the use of monsunetuzumab therapy.
Dr Leonard discusses the complex landscape and management of patients with lymphoma, including the use of monsunetuzumab therapy.
Dr Leonard discusses the complex...
11/04/2021
Oncology
Dr Ruan
Videos
Jia Ruan, MD, PhD, Discusses the Current Treatment Landscape for T-Cell Lymphoma
11/01/2021
Dr Jia Ruan, discusses the current treatment landscape for patients with T-cell lymphomas.
Dr Jia Ruan, discusses the current treatment landscape for patients with T-cell lymphomas.
Dr Jia Ruan, discusses the...
11/01/2021
Oncology
Dr Ruan
Videos
Dr Ruan Highlights Hot Topics in the Lymphoma Space
10/10/2021
Jia Ruan, MD, PhD, highlights various hot topics being discussed in the lymphoma space.
Jia Ruan, MD, PhD, highlights various hot topics being discussed in the lymphoma space.
Jia Ruan, MD, PhD, highlights...
10/10/2021
Oncology
Dr Evans Discusses Updates in the Treatment of Patients With FL
Videos
Dr Evans Discusses Updates in the Treatment of Patients With FL
01/29/2021
In this video, Andrew Evens, DO, MSc, FACP, discusses a couple of key publications and data sets in the field of EZH2-mutated and EZH2 wild type FL.
In this video, Andrew Evens, DO, MSc, FACP, discusses a couple of key publications and data sets in the field of EZH2-mutated and EZH2 wild type FL.
In this video, Andrew Evens, DO,...
01/29/2021
Oncology
Dr Cook Talks Advancements in the Treatment of FL With EZH2 Inhibitors
Videos
Dr Cook Talks Advancements in the Treatment of FL With EZH2 Inhibitors
11/01/2020
Perry C. Cook, MD, talks about progress made in the use of EZH2 inhibitors for the treatment of patients with FL.
Perry C. Cook, MD, talks about progress made in the use of EZH2 inhibitors for the treatment of patients with FL.
Perry C. Cook, MD, talks about...
11/01/2020
Oncology

Advertisement

Advertisement

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use